Pharming announces commitment to build a new downstream manufacturing facility for RUCONEST®
Leiden, The Netherlands, 18 November 2020: Pharming Group N.V. (Euronext Amsterdam: PHARM) announces it has committed to building a new facility to expand the Company’s downstream processing capacity for its lead product, RUCONEST® (recombinant C1 esterase inhibitor (rhC1INH)). The downstream processing facility will include the purification, filtration and concentration of the starting material. Construction is […]
Brabantse Ontwikkelings Maatschappij BOM determined in investing at Pivot Park start-ups
“We see that the companies in which we participate view Pivot Park as an excellent place to locate” As the first shareholder to invest in Pivot Park, we are proud to have been involved in the campus from the start. Over the last eight years, we have helped a number of BOM-funded pharmaceutical start-ups find […]
